Discover 921 paid clinical trials in Hillsboro, Oregon. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 921
Long-Term Safety Study of Deucravacitinib Versus Ustekinumab in Participants With Psoriasis (PRAGMATYK)
for
Plaque Psoriasis
Location: Portland OR, Mill Creek WA, Medford OR, Surrey, Nanaimo,
Sponsor: Bristol-Myers Squibb
Sex: All
Age: 40+
Code: NCT07116967
Phase3, Recruiting
A Long-Term Study to Learn About The Study Medicine Called Ritlecitinib in Children With Severe Alopecia Areata.
for
Severe Alopecia Areata
Location: Portland OR, Encinitas CA, Albuquerque NM, El Paso TX,
Sponsor: Pfizer
Sex: All
Age: 6 - 14
Code: NCT07029828
Phase3, Recruiting
A Study of Baricitinib (LY3009104) in Children From 6 Years to Less Than 18 Years of Age With Alopecia Areata
Location: Portland OR, Sacramento CA, Palo Alto CA,
Sponsor: Stanford University
Sex: All
Age: 18+
Code: NCT05275972
Phase3, Recruiting
Clarifying the Optimal Application of SLT Therapy Trial
for
Glaucoma and Ocular Hypertension
Location: Portland OR, Spokane WA, Sacramento CA,
Sponsor: University of Pittsburgh
Sex: All
Age: 18+
Code: NCT04967989
Phase3, Recruiting
Ripasudil for Enhanced Corneal Clearing Following Descemet Membrane Endothelial Keratoplasty in Fuchs' Dystrophy
for
Fuchs Endothelial Dystrophy
Location: Portland OR
Sponsor: Michael D. Straiko, MD
Sex: All
Age: 30 - 70+
Code: NCT03813056
Phase2, Recruiting
Study of SGR-1505 in Mature B-Cell Neoplasms
for
Mature B-Cell Neoplasm, Non Hodgkin Lymphoma, DLBCL,
Location: Portland OR, Seattle WA, Gilbert AZ, Dallas TX,
Sponsor: Schrödinger, Inc.
Sex: All
Age: 18+
Code: NCT05544019
Phase1, Recruiting
Study of Trastuzumab Deruxtecan With Bevacizumab Versus Bevacizumab Monotherapy for First-line Maintenance in HER2-Expressing Ovarian Cancer (DESTINY-Ovarian01)
for
Ovarian Cancer
Location: Portland OR, Palo Alto CA, Salt Lake City UT,
Sponsor: Daiichi Sankyo
Sex: Female
Age: 18+
Code: NCT06819007
Phase3, Recruiting
Safety and Efficacy of Bivalirudin Versus Heparin for Systemic Anticoagulation in Extracorporeal Membrane Oxygenation
for
Extracorporeal Membrane Oxygenation Complication,
Location: Portland OR
Sponsor: Legacy Health System
Sex: All
Age: 18+
Code: NCT03965208
Recruiting
Adding an Immunotherapy Drug, MEDI4736 (Durvalumab), to the Usual Chemotherapy Treatment (Paclitaxel, Cyclophosphamide, and Doxorubicin) for Stage II-III Breast Cancer
for
Anatomic Stage II Breast Cancer AJCC v8,
Location: Fruitland ID, Post Falls ID, Coeur d'Alene ID,
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 18+
Code: NCT06058377
Phase3, Recruiting
Testing Olaparib for One or Two Years, With or Without Bevacizumab, to Treat Ovarian Cancer
for
Fallopian Tube Endometrioid Adenocarcinoma,
Location: Tualatin OR, Portland OR, Newberg OR, Vancouver WA,
Sponsor: NRG Oncology
Sex: All
Age: 18+
Code: NCT06580314
Phase3, Recruiting
Human Menopausal Gonadotropin Research in Infertility Assessing Cumulative Live Birth With Frozen Embryo Transfer.
for
Infertility (IVF Patients)
Location: Portland OR, Encino CA, Bedford TX, Chicago IL,